Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
CrossRef Hepatobiliary Cancers in Saudi Arabia From 2000 to 2025 Khalil I Alshammari, Ibrahim Ginawi, Hisham Sherfi, Hussain G Ahmed Cureus .2025;[Epub] CrossRef Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma Kaiming He, Desheng Chen, Dongzi Zhu, Wenjie Zheng, Lei Lyu, Mingshen Zhang, Zeping Chen, Xiaowen Wang, Yongwei Hu, Binsheng Fu Journal of Nanobiotechnology .2025;[Epub] CrossRef Application of LI-RADS CT/MRI Radiation Treatment Response Assessment Version 2024: a study after transarterial radioembolization for hepatocellular carcinoma Jaeseung Shin, Sunyoung Lee, Ja Kyung Yoon, Kyowon Gu, Sun-Young Baek, Dong-Ho Hyun, Gyoung Min Kim, Jong Yun Won Japanese Journal of Radiology .2025
PlexusDx compounded GLP-1 optionsincluding semaglutide, tirzepatide, and microdose protocolsoffer dosing flexibility
How Do You Choose the Right GLP-1 for Weight Loss Success
RNA expression of select AML markers in NPM1 -mutated AML-8 subtypes
For IBS patients interested in exploring GLP-1 therapy, the Precision Peptide Genetic Test ($99 add-on after first month of treatment) provides personalized insights into whether your genetic profile suggests a favorable response to semaglutide injections or whether an alternative approach might be more appropriate
The SURPASS-2 trial directly compared tirzepatide to semaglutide 1.0 mg in patients with type 2 diabetes, providing the cleanest head-to-head data available
US$ 28.75
US$ 24.62
US$ 22.86
US$ 25.89
